Biotech firm anticipates coronavirus vaccine in 3 months

As the number of novel coronavirus cases surpassed 20,000 worldwide Monday, the rush is on to develop drugs to treat it and prevent further spread. Gaithersburg, Maryland-based biotechnology firm Novavax is among them.